PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.5592021531123-130Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER ProjectYoungwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kimhttp://e-crt.org/upload/pdf/crt-2020-559.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.559, http://e-crt.org/upload/pdf/crt-2020-559.pdf
Exploration of Targeted Anti-tumor Therapy10.37349/etat.2020.0000420201153-70Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinomaAnna Maria Rachiglio, Alessandra Sacco, Laura Forgione, Claudia Esposito, Nicoletta Chicchinelli, Nicola Normannohttps://www.explorationpub.com/Journals/etat/Article/10024
Clinical Colorectal Cancer10.1016/j.clcc.2012.08.001201312273-85Targeted Therapy for Metastatic Colorectal Cancer: Role of AfliberceptEdith P. Mitchellhttps://api.elsevier.com/content/article/PII:S1533002812001065?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002812001065?httpAccept=text/plain
Clinical Colorectal Cancer10.3816/ccc.2008.s.00720087S47-S51First-Line Treatment of Patients with Metastatic Colorectal Cancer: An Overview of Recent Data on Chemotherapy plus Targeted AgentsAndrea Cercek, Leonard B. Saltzhttps://api.elsevier.com/content/article/PII:S1533002811704571?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811704571?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2014.02.0012014133135-144Sequencing of Antiangiogenic Agents in the Treatment of Metastatic Colorectal CancerJames J. Lee, Edward Chuhttps://api.elsevier.com/content/article/PII:S1533002814000322?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002814000322?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2011.06.0112011104266-278Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal CancerEamon Berge, Chris Thompson, Wells Messersmithhttps://api.elsevier.com/content/article/PII:S1533002811001095?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811001095?httpAccept=text/plain
Clinical Colorectal Cancer10.3816/ccc.2010.n.040201095274-281Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal CancerUzma Asghar, Eliza Hawkes, David Cunninghamhttps://api.elsevier.com/content/article/PII:S1533002811700147?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811700147?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2011.05.00520121111-13An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal CancerEdward Chuhttps://api.elsevier.com/content/article/PII:S1533002811000442?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811000442?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/s1533-0028(11)70333-4200324235-238Clinical and Molecular Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based ChemotherapyRobin L. Jones, David Cunninghamhttps://api.elsevier.com/content/article/PII:S1533002811703334?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002811703334?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2012.06.0042012114247-254Survival Differences in Patients With Metastatic Colorectal Cancer and With Single Site Metastatic Disease at Initial Presentation: Results From South Australian Clinical Registry for Advanced Colorectal CancerMuhammad A. Khattak, Hilary L. Martin, Carol Beeke, Timothy Price, Scott Carruthers, Susan Kim, Robert Padbury, Christos S. Karapetishttps://api.elsevier.com/content/article/PII:S1533002812000746?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002812000746?httpAccept=text/plain